ACTUATE THERAPEUTICS (ACTU) director awarded 15,000 stock options at $2.42

Q: What is the exercise price of the stock options granted to the ACTU director?

The stock options have an exercise price of $2.4200 per share . This means Huber can acquire ACTU common shares at that price upon exercise, subject to vesting and other terms specified in the award and the company’s equity plan.

Q: When do the ACTU stock options granted to Martin H. Huber Jr. expire?

The options expire on May 21, 2036 , giving a long exercise window after vesting. After this expiration date, any unexercised options will lapse and no longer provide the right to purchase ACTU common shares at the set exercise price.

Q: Is this ACTU Form 4 transaction a market buy or sell of common stock?

No, the filing shows a grant/award acquisition of stock options, not a market trade. Code “A” indicates a compensation-related award, so there is no open-market buying or selling of ACTU common shares in this specific transaction.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

ACTUATE THERAPEUTICS, INC. director Martin H. Huber Jr. received a grant of stock options covering 15,000 shares of common stock. The options have an exercise price of $2.4200 per share and expire on May 21, 2036. According to the filing, these options will vest in full on the anniversary of the grant date. Following this award, the filing shows Huber holding 15,000 stock options directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Huber Martin H. Jr.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Options	15,000	$0.00	--

Holdings After Transaction: Stock Options — 15,000 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Options granted: 15,000 options Exercise price: $2.4200 per share Expiration date: May 21, 2036 +2 more

5 metrics

Options granted 15,000 options Stock options award to director on May 21, 2026

Exercise price $2.4200 per share Strike price for the 15,000 stock options

Expiration date May 21, 2036 Option term for the granted stock options

Underlying shares 15,000 shares Common stock underlying the options grant

Post-grant derivative holdings 15,000 options Total stock options held directly after transaction

Key Terms

Stock Options, grant/award acquisition, exercise price, Common Stock, +1 more

5 terms

Stock Options financial

"security_title: "Stock Options""

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

grant/award acquisition financial

"transaction_action: "grant/award acquisition""

exercise price financial

"conversion_or_exercise_price: "2.4200""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

vest in full financial

"Options will vest in full on the anniversary of the grant date."

Form 4 Insider Transactions: What Each Field Means →

05/22/2026 - 04:03 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Huber Martin H. Jr.

(Last)

(First)

(Middle)

C/O ACTUATE THERAPEUTICS, INC.

1751 RIVER RUN, SUITE 400

(Street)

FORT WORTH

TEXAS

76107

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ACTUATE THERAPEUTICS, INC. [ ACTU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Options	$2.42	05/21/2026		A		15,000		⁽¹⁾	05/21/2036	Common Stock	15,000	$0	15,000	D

Explanation of Responses:

1. Options will vest in full on the anniversary of the grant date.

	/s/ Paul Lytle, Attorney-in-Fact	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did ACTU director Martin H. Huber Jr. report in this Form 4 for ACTU?

He reported receiving a grant of stock options for 15,000 shares of ACTU common stock. These options were awarded as a compensation-related grant, not an open-market purchase, and are classified as a derivative security in the filing.

What is the exercise price of the stock options granted to the ACTU director?

The stock options have an exercise price of $2.4200 per share. This means Huber can acquire ACTU common shares at that price upon exercise, subject to vesting and other terms specified in the award and the company’s equity plan.

When do the newly granted ACTU stock options vest for the director?

The options will vest in full on the anniversary of the grant date. This one-year cliff vesting means Huber must remain eligible through that date before any of the 15,000 options become exercisable into common stock.

When do the ACTU stock options granted to Martin H. Huber Jr. expire?

The options expire on May 21, 2036, giving a long exercise window after vesting. After this expiration date, any unexercised options will lapse and no longer provide the right to purchase ACTU common shares at the set exercise price.

How many stock options does the ACTU director hold after this reported grant?

After the reported transaction, the filing shows Huber holding 15,000 stock options directly. This total reflects the newly granted options and represents his derivative position as of the transaction date disclosed in the Form 4.

Is this ACTU Form 4 transaction a market buy or sell of common stock?

No, the filing shows a grant/award acquisition of stock options, not a market trade. Code “A” indicates a compensation-related award, so there is no open-market buying or selling of ACTU common shares in this specific transaction.